Article original2026
Patrick Kabongo Mutombo, Gédéon Kalala Tshimanga, Hypolite Muhindo Mavoko, Kabongo Mutombo P, Kalala Tshimanga G, Hypo Mavoko JP
Whole-genome sequencing of 248 Mpox virus isolates from 14 provinces in DRC reveals substantial genetic diversity and identifies novel clades with potential implications for vaccine efficacy.
Article original2026
Marie-Claire Mukendi Ngoy, Gracia Tshibangu Lukusa, Mukendi Ngoy MC, Tshibangu Lukusa G
This multicentre randomised phase III trial demonstrates non-inferiority of oral fexinidazole compared to the standard NECT regimen for stage 2 HAT, with a cure rate of 95.2% vs 93.8% at 18 months.